Nashville Breast Center

Nashville, Tennessee 37205

3 studies enrolling now · 19 studies all time

What they study most

Anxiety, Appetite Disorders, Arthralgia, Breast Adenocarcinoma, Breast Cancer, Breast Ductal Carcinoma In Situ, Breast Lesions, Breast Neoplasms, Chronic Pain, DCIS, Ductal Breast Carcinoma In Situ, Estrogen Receptor-positive Breast Cancer

Studies at this site

• The PREDICT Registry: — Recruiting now
• MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression Profiles — Recruiting now
• Tamoxifen Citrate, Letrozole, Anastrozole, or Exemestane With or Without Chemotherapy in Treating Patients With Invasive RxPONDER Breast Cancer — Running, not enrolling
• Hormone Therapy With or Without Combination Chemotherapy in Treating Women Who Have Undergone Surgery for Node-Negative Breast Cancer (The TAILORx Trial) — Running, not enrolling
• Comparison of Axillary Lymph Node Dissection With Axillary Radiation for Patients With Node-Positive Breast Cancer Treated With Chemotherapy — Running, not enrolling
• Fulvestrant and/or Anastrozole in Treating Postmenopausal Patients With Stage II-III Breast Cancer Undergoing Surgery — Running, not enrolling
• S1207 Hormone Therapy With or Without Everolimus in Treating Patients With Breast Cancer — Running, not enrolling
• Testosterone in Treating Postmenopausal Patients With Arthralgia Caused by Adjuvant Aromatase Inhibitor Treatment — Completed
• Surgery to Remove the Sentinel Lymph Node and Axillary Lymph Nodes After Chemotherapy in Treating Women With Stage II, Stage IIIA, or Stage IIIB Breast Cancer — Completed
• The JULI Registry--Hemp and Cannabis Observational Registry — Status unconfirmed
• The Informed Genetics Annotated Patient Registry — Enrolling by invitation
• Study Evaluating The Effects Of Neratinib After Adjuvant Trastuzumab In Women With Early Stage Breast Cancer — Completed
• NBRST: Prospective Neo-adjuvant REGISTRY Trial — Completed
• A Registry Study Evaluating Outcomes in Breast Biopsy With the Intact™ Breast Lesion Excision System (BLES) — Stopped early
• Combination Chemotherapy and Paclitaxel Plus Trastuzumab in Treating Women With Palpable Breast Cancer That Can Be Removed by Surgery — Completed
• PRospective Study Of MammaPrint in Patients With an Intermediate Recurrence Score — Completed
• TME Neoadjuvant Breast Registry — Status unconfirmed
• Percutaneous Excision Trial — Completed
• Chemotherapy Drug Sensitivity Microculture (MiCK) Assay for Apoptosis — Completed